Skip to main content

T. Rowe Price Investment Management, Inc.

Position in IMVT — Immunovant, Inc.

CIK 1897612 BALTIMORE, MD

Position in IMVT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$89,743,442
-$38,891,900 QoQ
Shares Held
3,612,860
-28.6% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. IMVT ranks #21 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMVT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $89,743,442 3,612,860
2025-12-31 $128,635,342 5,060,399
2025-09-30 $83,254,931 5,164,698
2025-06-30 $110,063,296 6,878,956
2025-03-31 $100,742,542 5,894,824
2024-12-31 $126,753,886 5,117,234
2024-09-30 $94,967,294 3,331,017
2024-06-30 $42,905,808 1,625,220